Drug profile · INN
estradiol cypionate
DEPO-ESTRADIOL
estradiol cypionate (DEPO-ESTRADIOL) is a estrogen receptor alpha agonist. Route of administration: intramuscular. Current US regulatory status: approved.
Drug details — estradiol cypionate
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
estradiol cypionate (DEPO-ESTRADIOL) is a estrogen receptor alpha agonist. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor alpha agonist
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is estradiol cypionate?
estradiol cypionate (DEPO-ESTRADIOL) is a estrogen receptor alpha agonist. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for estradiol cypionate?
DEPO-ESTRADIOL is a marketed brand name for estradiol cypionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of estradiol cypionate?
estradiol cypionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.